Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents
Yong Jian,Gengshen Mo,Weiyuan Xu,Yao Liu,Zhichao Zhang,Yinghui Ding,Ruonan Gao,Jiao Xu,Jiang Zhu,Kun Shu,Zhihan Yan,Fabio Carniato,Carlos Platas-Iglesias,Fangfu Ye,Mauro Botta,Lixiong Dai
DOI: https://doi.org/10.1021/acs.inorgchem.4c01028
IF: 4.6
2024-04-21
Inorganic Chemistry
Abstract:In recent years, pyclen-based complexes have attracted a great deal of interest as magnetic resonance imaging (MRI) contrast agents (CAs) and luminescent materials, as well as radiopharmaceuticals. Remarkably, gadopiclenol, a Gd(III) bishydrated complex featuring a pyclen-based heptadentate ligand, received approval as a novel contrast agent for clinical MRI application in 2022. To maximize stability and efficiency, two novel chiral pyclen-based chelators and their complexes were developed in...
chemistry, inorganic & nuclear